ReviewSpringerPlus2016

Daclatasvir combined with peginterferon-α and ribavirin for the treatment of chronic hepatitis C: a meta-analysis.

Qin Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.